CJC-1295 & Ipamorelin Blend (10mg) Research Peptide: A Synergistic GH & IGF-1 Research Tool

If your research explores the hypothalamic-pituitary-somatotropic axis, the dynamics of growth hormone (GH) secretion, or the downstream effects of insulin-like growth factor 1 (IGF-1), the CJC-1295 & Ipamorelin Blend (10mg) research peptide offers a precisely defined, dual-pathway experimental platform. This 10 mg formulation combines two well‑characterised GH secretagogues—CJC-1295 (Mod GRF 1-29) and Ipamorelin—each acting through complementary mechanisms to stimulate the body’s natural GH release. 

By simultaneously targeting the GHRH receptor and the ghrelin receptor (GHS-R1a), this blend allows researchers to model the synergistic interplay between these two major regulatory pathways, providing deeper insight into the circuits that govern GH pulsatility and IGF-1 signalling.

At Wuhan Top Miracle Peptides, we supply high‑purity CJC-1295 & Ipamorelin Blend (10mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥98% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into GH regulation, IGF‑1 signalling, and metabolic research begin with uncompromising quality.

What Is the CJC-1295 & Ipamorelin Blend and How Does It Work?

To fully appreciate the research potential of the CJC-1295 & Ipamorelin Blend (10mg) research peptide, it is essential to understand the distinct yet complementary mechanisms of its two components. Each peptide activates a different receptor class, yet both converge on the somatotroph cells of the anterior pituitary to stimulate GH synthesis and release.

CJC-1295 (Mod GRF 1-29): The Stabilised GHRH Analogue

CJC-1295 in this blend is the “no DAC” (Drug Affinity Complex) variant, also referred to as Modified GRF 1-29. It is a synthetic peptide derived from the 29-amino-acid fragment of human growth hormone-releasing hormone (GHRH). CJC-1295 features four specific amino acid substitutions—at positions 2, 8, 15, and 27—that enhance its stability and render it resistant to enzymatic degradation.

As a GHRH analogue, it binds to GHRH receptors (GHRHR) on pituitary somatotroph cells, stimulating the synthesis and pulsatile release of endogenous growth hormone. The “no DAC” variant has a half-life of approximately 30 minutes and produces sharp, natural GH spikes that mimic the body’s own pulsatile rhythm, making it the preferred form for protocols that aim to replicate physiological GH secretion.

Ipamorelin: The Selective Ghrelin Receptor Agonist

Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue. It was first described in the European Journal of Endocrinology as “the first selective growth hormone secretagogue.” Ipamorelin binds to the ghrelin receptor (GHS-R1a), a class A GPCR expressed on somatotrophs and hypothalamic neurons. A key research advantage is its selectivity: it stimulates GH release without significantly elevating cortisol, ACTH, or prolactin, even at doses well above those required for GH stimulation. This high specificity distinguishes it from earlier, non-selective secretagogues and makes it a cleaner tool for studying GH dynamics.

Mechanism of Synergy: Dual‑Pathway Activation

The scientific rationale for combining CJC‑1295 and Ipamorelin lies in their convergent yet distinct mechanisms. CJC‑1295 binds to the GHRH receptor and signals via the cAMP/PKA pathway, driving GH synthesis and transcriptional priming. Ipamorelin, on the other hand, binds to the ghrelin receptor and signals via the Ca²⁺/PKC pathway, triggering immediate GH exocytosis.

When co‑activated, these two pathways converge on the somatotroph to produce GH pulses with both larger amplitude and greater secretory reserve than either pathway alone. This dual-pathway co-activation yields a synergistic GH response—studies have shown that the combination produces up to 3–5 times higher GH release than either peptide alone. The combined-stack rationale—GHRH analogue plus ghrelin receptor agonist—was established in the 1990s and has since become the dominant design in growth-hormone peptide research.

Key Research Applications for the CJC-1295 & Ipamorelin Blend (10mg)

The CJC-1295 & Ipamorelin Blend (10mg) research peptide is a versatile tool with applications spanning several domains of biomedical research.

1. Growth Hormone Axis & Pituitary Function Studies

This blend provides a powerful model for investigating the hypothalamic‑pituitary‑somatotropic axis. Researchers can use it to study:

• The synergistic effects of GHRH and ghrelin pathway co‑activation on GH synthesis, storage, and pulsatile release.

• The distinct contributions of GHRH‑mediated and ghrelin‑mediated signalling to overall GH secretion.

• The dynamics of GH pulse amplitude and frequency in response to dual‑pathway stimulation.

• The influence of combinatorial pathway effects on second‑messenger outputs.

2. Metabolic & Body Composition Research

By stimulating endogenous GH release through two pathways, this blend provides a model for studying the downstream metabolic effects of GH and IGF‑1 elevation. Research applications include:

• Lipid Metabolism: Exploring the role of GH in lipolysis and fat metabolism.

• Glucose Homeostasis: Investigating how GH modulation impacts glucose regulation and insulin sensitivity.

• Body Composition: Studying how enhanced GH secretion may influence lean tissue accrual and reduce adipose deposition.

• Muscle Regeneration: Investigating the peptide’s potential to support muscle tissue recovery and hypertrophy.

3. Receptor Pharmacology & Signalling Research

The blend offers a multifaceted research modality for probing endogenous growth hormone axis mechanics. Researchers can use it to:

• Investigate the complex interplay between the GHRH and ghrelin systems.

• Study the downstream signalling pathways activated by GHRH and ghrelin receptor co‑stimulation.

• Characterise dual‑GPCR signalling and second‑messenger outputs in the context of GH regulation.

• Compare the pharmacokinetic profiles of CJC‑1295 (with and without DAC) in combined-stack protocols.

4. Recovery & Regenerative Research

GH and IGF‑1 are central to anabolic signalling cascades involved in protein synthesis and cellular growth. Research applications include:

• Recovery from Injury: Investigating the potential of amplified GH‑IGF‑1 signalling to support tissue repair.

• Connective Tissue Remodelling: Exploring the effects of enhanced GH secretion on collagen and extracellular matrix dynamics.

• Neuroprotective Research: Investigating GH‑mediated neuroprotective properties in degenerative research models.

Chemical & Physical Specifications for CJC-1295 & Ipamorelin Blend (10mg)

Accurate characterisation of the CJC-1295 & Ipamorelin Blend (10mg) research peptide is essential for reproducible experimental design. The blend is typically supplied as a 1:1 ratio of each component, though exact ratios may vary by formulation.

Note: The 10 mg mass represents the total peptide weight of the blend. The exact ratio of CJC‑1295 (Mod GRF 1‑29) to Ipamorelin is determined by the formulation (contact for details). The blend is supplied in a single lyophilised vial. CJC‑1295 in this blend does not contain the Drug Affinity Complex (DAC) moiety, which preserves a more pulsatile release pattern that mimics natural physiology.

Reconstitution & Handling Protocol for the CJC-1295 & Ipamorelin Blend (10mg)

Proper reconstitution of the CJC-1295 & Ipamorelin Blend (10mg) research peptide is critical for maintaining the structural integrity and biological activity of both peptides. This aseptic protocol ensures optimal stability for your experiments.

Step 1 – Preparation

• Bring the sealed blend vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the blend vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 10 mg per 2 mL of diluent, yielding a 5 mg/mL total peptide concentration (or 5000 mcg/mL).

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted peptide blend into single‑use sterile vials.

• Store aliquots at -20°C for up to 6 months. Avoid repeated freeze‑thaw cycles.

• Once thawed, store at 4°C and use within 4 weeks.

Concentration Reference Table for CJC-1295 & Ipamorelin Blend (10mg)

Adjust diluent volume based on your experimental requirements. The exact concentration of each individual peptide within the blend is determined by the formulation’s component ratio.

Storage & Stability Guidelines for CJC-1295 & Ipamorelin Blend (10mg)

Why Choose Wuhan Top Miracle Peptides for the CJC-1295 & Ipamorelin Blend (10mg)?

As an authentic licensed peptide supplier based in the United Kingdom, we supply the CJC-1295 & Ipamorelin Blend (10mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent third-party HPLC analysis with purity guaranteed ≥99% for each component, every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Lot‑Level Documentation: Supplied with lot‑level traceability to support research documentation and laboratory recordkeeping.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• UK‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).

Researchers across the United Kingdom—including those at leading institutions in London, Cambridge, Oxford, Manchester, and Edinburgh—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: CJC-1295 & Ipamorelin Blend (10mg) Research Peptide

What is the CJC-1295 & Ipamorelin Blend (10mg) research peptide?
It is a research‑grade formulation combining CJC‑1295 (Mod GRF 1‑29, a modified GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). It is used as a dual‑pathway tool to study growth hormone stimulation, IGF‑1 signalling, and metabolic research.

How does each component work?
CJC‑1295 (Mod GRF 1‑29) binds to GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and release via the cAMP/PKA pathway. Ipamorelin binds to the growth hormone secretagogue receptor (GHS‑R1a), amplifying GH release via the Ca²⁺/PKC pathway without elevating cortisol, ACTH, or prolactin.

What is the proposed synergy between CJC‑1295 and Ipamorelin?
CJC‑1295 provides the primary stimulus to initiate GH production, while Ipamorelin enhances the amplitude of that response. Studies show that the combination produces up to 3–5 times higher GH release than either peptide alone.

What is the difference between CJC‑1295 with DAC and without DAC?
CJC‑1295 without DAC (Mod GRF 1‑29) does not contain a drug affinity complex moiety and has a half‑life of approximately 30 minutes. The version without DAC supports a more pulsatile release pattern that closely mimics natural physiology. CJC‑1295 with DAC has a half‑life of approximately 6‑8 days and produces a sustained, continuous GH bleed.

What purity does your CJC‑1295 & Ipamorelin Blend (10mg) meet?
Each component is tested to ≥99% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

How should I reconstitute this peptide blend?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake. A typical concentration is 5 mg/mL (2 mL diluent per 10 mg vial).

How should I store reconstituted peptide blends?
Reconstituted blends should be stored at 4°C and used within 4 weeks. For longer storage, aliquot immediately into single‑use vials and store at -20°C for up to 6 months. Avoid repeated freeze‑thaw cycles.

Is this peptide blend legal to purchase in the UK for research?
Yes. This blend is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United Kingdom for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: CJC‑1295 and Ipamorelin are not approved for human use and are prohibited by the World Anti‑Doping Agency (WADA) for athletic use.

Does Wuhan Top Miracle Peptides ship internationally?
Yes. We ship across the EU (France, Germany, Spain, Sweden, Italy) and to the USA from our UK warehouse. Wholesale pricing is available for bulk orders.

Wholesale CJC-1295 & Ipamorelin Blend (10mg) Supply Across the UK and Europe

Wuhan Top Miracle Peptides supports wholesale peptide blend buyers in the United Kingdom and international markets.

We Support Enquiries From:

• United Kingdom
• France
• Germany
• Spain
• Sweden
• Italy
• USA
• Wider Europe

For larger blend enquiries, contact our team before ordering. This helps confirm stock, documentation, shipping options, component identity, blend ratio, DAC status, and buyer verification requirements.

Where to Source CJC-1295 & Ipamorelin Blend (10mg) in the UK

If you are searching for where to source CJC-1295 & Ipamorelin Blend (10mg) in the UK, Wuhan Top Miracle Peptides provides a simple professional enquiry process.

Professional Enquiry Process

1. Review the blend product details.
2. Check the current label and batch information.
3. Confirm whether the batch lists CJC-1295 or another documented identity.
4. Confirm whether the CJC component includes DAC.
5. Confirm whether Ipamorelin is listed as a component.
6. Ask about the total vial content and blend ratio.
7. Ask about COA and purity-related documentation.
8. Confirm sequence and salt form for each component where required.
9. Confirm your shipping country.
10. Discuss wholesale quantity requirements.
11. Complete buyer verification where required.
12. Place a professional enquiry with support from our team.

CJC-1295 & Ipamorelin Blend (10mg)

Bulk Peptides Page
Shipping & Returns Page
Contact Us Page
Shop Page
Quality / Compliance Page
CJC-1295 Product Page
Ipamorelin Product Page
Mod GRF 1-29 Product Page
PubChem / compound reference source
PubChem / compound reference source
GOV.UK / MHRA
Google Search Central
ASA / CAP Code Section 12

CJC-1295 & Ipamorelin Blend (10mg)

From its innovative design as a dual‑pathway GH secretagogue blend to its well‑documented role in modelling the synergistic interplay between the GHRH and ghrelin systems, the CJC-1295 & Ipamorelin Blend (10mg) research peptide provides a uniquely versatile platform for advanced endocrinological and metabolic research.

Its ability to stimulate endogenous GH release through two distinct yet convergent pathways—CJC‑1295 providing sustained baseline stimulation via GHRHR and Ipamorelin inducing pulsatile amplification via GHSR—supported by peer‑reviewed research published in PubMed, European Journal of Endocrinology, and other authoritative journals, makes it a valuable addition to any laboratory investigating the GH/IGF‑1 axis. By choosing high‑purity, lab‑verified CJC-1295 & Ipamorelin Blend (10mg) research peptide from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with the CJC-1295 & Ipamorelin Blend (10mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade research peptides delivered directly to your facility in the UK, EU, or USA.